Green tea could block benefits of cancer drugFebruary 4th, 2009 - 10:49 am ICT by ANI
Washington, Feb 4 (ANI): The health benefits of green tea have come under scanner following a new research which has found that the healthy drink could reduce the effectiveness of one kind of chemotherapy treatment.
Researchers at the University of Southern California (USC) have found that the widely used supplement renders a cancer drug used to treat multiple myeloma and mantle cell lymphoma completely ineffective in treating cancer.
The study found that a component of green tea extract (GTE) called EGCG destroys any anticancer activity of the drug Velcade in tumor-bearing mice.
The study will be published in the journal Blood.
“Our finding that GTE or EGCG blocked the therapeutic action of Velcade was completely unexpected,” says lead author Axel H. Schonthal, PhD, associate professor in the Department of Microbiology and Immunology at the Keck School of Medicine of USC.
“Our hypothesis was that GTE or EGCG would enhance the anti-tumor effects of Velcade, and that a combination of GTE with Velcade (or EGCG with Velcade) would turn out to be a superior cancer treatment as compared to treatment with Velcade alone, the expert added.
Using preclinical models and tumor-bearing mice, the researchers found that the unusually effective blockage of Velcade’’s therapeutic activity was based on the chemical interaction between molecules. The EGCG molecule and the Velcade molecule were able to form chemical bonds, meaning that the Velcade molecule could no longer bind to its intended target inside the tumor cells.
“The most immediate conclusion from our study is the strong advice that patients undergoing cancer therapy with Velcade must avoid green tea, and in particular all of its concentrated products that are freely available from health food stores,” says Schonthal.
“It is important to spread this message to health care providers who administer Velcade to patients, the researcher added. (ANI)
- Green tea boosts memory - Sep 06, 2012
- Compounds offer novel approach to fight cancer - Nov 02, 2010
- Green tea may help treat chronic leukemia - Jun 05, 2010
- How red wine and green tea can prevent prostate cancer growth - Jun 10, 2010
- New 'nanodrug' can attack breast cancer cells from the inside out - Mar 30, 2011
- Bone marrow cancer drug could be used to treat rheumatoid arthritis - Nov 04, 2010
- 'Good cholesterol' nanoparticles may help fight cancer - Apr 02, 2011
- Ancient Chinese herbal recipe eases chemo's side effects - Aug 19, 2010
- Viagra, anti-cancer drug combo shrinks tumors in vivo - Sep 28, 2010
- Green tea chemical combined with another may help treat brain disorders - Dec 04, 2009
- Nanotechnology may lead to new liver cancer treatment - Feb 23, 2011
- Red wine compound 'can give a boost to breast cancer treatment' - Feb 15, 2011
- Soon, a 'nano drug' jab that hits brain tumour's bullseye - Nov 06, 2010
- New tool opens alternate door to prostate cancer diagnosis - Apr 03, 2011
- Marijuana causes testicular cancer - Sep 10, 2012
Tags: anticancer activity, benefits of green tea, cancer drug, cancer therapy, chemical bonds, chemical interaction, green tea extract, health benefits of green tea, health care providers, health food stores, journal blood, keck school of medicine, mantle cell lymphoma, microbiology and immunology, multiple myeloma, target, therapeutic action, therapeutic activity, university of southern california, velcade